Retatrutide
Triple Receptor Agonist
Retatrutide (Triple Receptor Agonist) is a research-grade peptide supplied by Living Water Labs for laboratory investigation. Advanced triple-receptor metabolic optimisation. Each batch is HPLC-verified to a minimum 98% purity with a batch-specific Certificate of Analysis. The summary below outlines documented mechanisms and study areas reported in the research literature.
Scientific name
LY3437943 (GLP-1/GIP/Glucagon Receptor Triagonist)
Molecular weight
4735.5 g/mol
Purity
98.7%
Vial size
30mg
DOCUMENTED RESEARCH AREAS
- ▸Triple incretin receptor activity (GLP-1, GIP, glucagon) studied in metabolic-pathway research
- ▸Body-weight and metabolic endpoints evaluated in clinical research trials
- ▸Insulin-signalling and glucose-metabolism pathways studied in preclinical models
- ▸Glucagon-mediated thermogenesis markers studied in metabolic research
- ▸Hepatic lipid-accumulation markers studied in metabolic research models
- ▸Acts on hypothalamic and gut-brain-axis satiety signalling in research models
- ▸Lean-mass markers studied relative to body-composition endpoints
CITED LITERATURE (PUBMED)
All information is provided for research and educational purposes only and describes findings in preclinical/in-vitro literature. Not medical advice. Products are supplied strictly for research purposes — not for human or animal consumption.